| Fadel Bofarrag, MD | |
|
585 Lebanon St, Melrose, MA 02176-3225 | |
| (800) 424-3672 | |
| (314) 434-5939 |
| Full Name | Fadel Bofarrag |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 14 Years |
| Location | 585 Lebanon St, Melrose, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003291279 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lahey Clinic Inc | 2264336528 | 1211 |
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Entity Name | Massachusetts Acute Care Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306134812 PECOS PAC ID: 9234303082 Enrollment ID: O20111114000448 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fadel Bofarrag, MD 5870 Hiatus Rd, Tamarac, FL 33321-6424 Ph: (954) 377-3025 | Fadel Bofarrag, MD 585 Lebanon St, Melrose, MA 02176-3225 Ph: (800) 424-3672 |
News Archive
In this post in PSI's "Healthy Living" blog, Mannasseh Phiri, PSI's country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project "to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia's prisons."
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
U.S. District Judge Christina Snyder has amended her order reversing a 10% reduction in Medi-Cal reimbursement rates for health care providers to require repayment only for services performed on or after Aug. 18, which effectively "spares the state from tens of millions of dollars" in reimbursements, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 9/4).
The trucks and trains that transport goods across the United States emit gases and particles that threaten human health and the environment.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
› Verified 1 days ago
Kashif Samad, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 | |
Badal Kalamkar, MD, MPH Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 | |
Julie Chiu, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 718-604-5401 | |
Chong Shou, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3861 Fax: 781-979-3860 | |
Udayasena Reddy Dendi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 |